Dynavax Technologies Corporation (DVAX) earnings
DVAX earnings moved a median of -0.28% by the close. Quarterly and annual DVAX reports and results, each read against the price at its own news timestamp. Back to the DVAX overview →
23 measured DVAX earnings events.
Where these DVAX earnings landedvs 23 measured DVAX earnings reactions
| Middle 50% of DVAX earnings reactions | -4.09% to +1.47% |
|---|---|
| Median reaction (to close) | -0.28% |
| Measured reactions | 23 |
Point-in-time · zero look-ahead
Half of the 23 DVAX earnings events with a measured close landed between -4.09% and +1.47%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program | Press release | +3.55% | +3.29% | |
| Form 10-Q DYNAVAX TECHNOLOGIES For: Sep 30 | SEC filing · Form 10-Q | +3.55% | +3.29% | |
| Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025 | Press release | +0.40% | +0.69% | |
| Dynavax Reports Second Quarter 2025 Financial Results | Press release | -8.70% | -14.35% | |
| Form 10-Q DYNAVAX TECHNOLOGIES For: Jun 30 | SEC filing · Form 10-Q | -8.70% | -14.35% | |
| Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 | Press release | -0.13% | -1.41% | |
| Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs | Press release | -0.14% | -7.87% | |
| Form 10-Q DYNAVAX TECHNOLOGIES For: Mar 31 | SEC filing · Form 10-Q | -0.14% | -7.87% | |
| Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025 | Press release | +0.83% | -0.28% | |
| Form 10-K DYNAVAX TECHNOLOGIES For: Dec 31 | SEC filing · Form 10-K | +0.29% | -3.62% | |
| Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | +6.76% | +4.08% | |
| Form 10-Q DYNAVAX TECHNOLOGIES For: Sep 30 | SEC filing · Form 10-Q | +6.76% | +4.08% | |
| Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024 | Press release | -0.37% | -1.11% | |
| Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates | Press release | -7.10% | +0.47% | |
| Form 10-Q DYNAVAX TECHNOLOGIES For: Jun 30 | SEC filing · Form 10-Q | -7.10% | +0.47% | |
| Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 | Press release | +0.37% | +2.56% | |
| Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | -1.96% | +0.09% | |
| Form 10-Q DYNAVAX TECHNOLOGIES For: Mar 31 | SEC filing · Form 10-Q | -1.96% | +0.09% | |
| Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 | Press release | -1.05% | -2.10% | |
| Form 10-K DYNAVAX TECHNOLOGIES For: Dec 31 | SEC filing · Form 10-K | -1.08% | +2.25% | |
| Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance | Press release | -3.62% | -4.56% | |
| Form 10-Q DYNAVAX TECHNOLOGIES For: Sep 30 | SEC filing · Form 10-Q | -3.62% | -4.56% | |
| Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023 | Press release | -0.57% | -1.25% |
Keep exploring
More DVAX: analyst actions → · SEC filings → · DVAX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| XOMA Royalty Corporation (XOMA) | 313 | 0.00% | 48% |
| Gen Digital Inc. (GEN) | 312 | +0.08% | 52% |
| National HealthCare Corporation (NHC) | 310 | 0.00% | 49% |
| NeuroOne Medical Technologies Corporation (NMTC) | 310 | -0.19% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.